Moving towards personalized therapy in CLL & sequencing BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 1:09 1 year ago 106 Далее Скачать
Moving towards a personalized treatment approach in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:59 1 year ago 68 Далее Скачать
Moving towards time-limited treatment in frontline CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:07 1 year ago 74 Далее Скачать
Era of personalized therapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 0:57 8 years ago 64 Далее Скачать
Moving towards personalized therapy for AML VJHemOnc – Video Journal of Hematology & HemOnc 1:07 8 years ago 220 Далее Скачать
Personalised medicine in CLL: Redefining the treatment approach VJHemOnc – Video Journal of Hematology & HemOnc 3:41 8 years ago 259 Далее Скачать
The movement towards targetted therapies in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:37 4 years ago 56 Далее Скачать
Moving towards chemo-free regimens in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:42 5 years ago 91 Далее Скачать
Getting the Most from Your CLL Treatment: Managing Side Effects and Knowing When to Stop CLL Society 1:30:16 2 days ago 185 Далее Скачать
The importance of treatment sequencing in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:29 1 year ago 304 Далее Скачать
Moving away from chemotherapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:29 6 years ago 284 Далее Скачать
Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL PeerView Oncology 1:02:27 3 years ago 206 Далее Скачать
ASH Highlights in CLL: moving towards fixed-duration treatment, the role of MRD & ALPINE results VJHemOnc – Video Journal of Hematology & HemOnc 2:09 1 year ago 157 Далее Скачать
CLL treatment: a look into the future VJHemOnc – Video Journal of Hematology & HemOnc 1:19 2 years ago 319 Далее Скачать
From chemotherapy towards targeted therapies in CLL VJHemOnc – Video Journal of Hematology & HemOnc 0:40 7 years ago 101 Далее Скачать
The future of CLL treatment and more personalized approaches VJHemOnc – Video Journal of Hematology & HemOnc 1:22 2 years ago 162 Далее Скачать
Factors to consider when selecting initial therapy in CLL: patient features & preference VJHemOnc – Video Journal of Hematology & HemOnc 1:41 1 year ago 324 Далее Скачать
Biomarker-guided therapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:43 2 years ago 341 Далее Скачать
Moving away from chemoimmunotherapy and towards novel targeted agents in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:57 2 weeks ago 60 Далее Скачать
